Determination of expression of platelet derived growth factor receptors (PDGFR) in astrocitic tumors

Autor: C. H. Barrios, F. S. Viola, E. Paglioli, L. M. Coutinho
Rok vydání: 2006
Předmět:
Zdroj: Journal of Clinical Oncology. 24:11518-11518
ISSN: 1527-7755
0732-183X
Popis: 11518 Background: PDGF and its receptors (α and β) are frequently expressed together in gliomas raising the possibility that an autocrine/paracrine loop could contribute to the pathogenesis of these tumors. Studies with immunohistochemistry (IHC) and in situ hybridization have clarified that PDGF-α receptors (PDGF-R α) are preferentially expressed in tumor cells, whereas PDGF-β receptors (PDGF-R β) are preferentially expressed in proliferating endotelial cells within the tumor vasculature. Objective: Determine the expression of PDGF-R α and β in astrocitic tumors. Methods: Paraffin blocks samples from patients with a diagnosis of low-grade astrocitoma, anaplastic astrocitoma, and glioblastoma were obtained from the Neuro-Oncology Unit at Hospital São Lucas-PUCRS. These patients presented and were treated from 1996 through 2001. We collected a total of 130 cases: 57 Low-grade astrocitomas (LGA), 13 Anaplastic Astrocitomas (AA), and 60 Glioblastomas (GBM). All cases were studied with standard IHC techniques using antibodies for PDGFR α and β (Santa Cruz Biotechnology). Results: See table . Conclusion: The expression of PDGF-R α and β in low-grade tumors reflects the possible role these receptors may have in the evolution of these neoplasms. More importantly we documented that over 60% of high-grade gliomas (61% in AA; 65% in GBM) show expression of PDGF-R β predominantly in the endothelial cell compartment of the tumors. This is consistent with and reflects the extensive angiogenesis observed in these diseases. The level of expression we encountered identifies an attractive molecular target to explore. [Table: see text] No significant financial relationships to disclose.
Databáze: OpenAIRE